Mission Pharmacal

What Mission Pharmacal does

Mission Pharmacal Company is a privately held, family-owned pharmaceutical manufacturer founded in 1946 in San Antonio, Texas, currently led by the third generation of the Walsdorf family. The company develops, manufactures, and markets branded prescription and over-the-counter pharmaceutical products across four therapeutic verticals: Women's Health (e.g., CitraNatal prenatal supplements, Ferralet iron supplement, Uribel for urinary tract health), Urology (Lithostat and Urocit-K for kidney stone disease, where it claims category leadership), Dermatology (AVAR, OVACE Plus, GLYDERM, Texacort), and a Consumer/Other line (Dr. Smith's Diaper Rash Ointment, Thera-Gesic, Oncovite, Potassium Iodide Oral Solution).

The company's operational backbone is a manufacturing, distribution, and R&D complex in Boerne, Texas that exceeds 300,000 square feet, with capacity to produce more than 1.5 billion tablets per year using over 450,000 pounds of raw material monthly across powders, tablets, solutions, creams, lotions, gels, and suspensions. Production operates under cGMP and is supported by Drug Distributor Accreditation from the National Association of Boards of Pharmacy.

Mission earns revenue through three channels: (1) branded pharmaceutical sales in the U.S. via an internal direct sales and marketing network structured for co-promotion and co-marketing, (2) generic pharmaceutical commercialization through wholly-owned subsidiary BioComp Pharma, Inc., which also offers turnkey labeling, warehousing, distribution, EDI, national account sales management, and marketing services to third parties, and (3) Contract Development and Manufacturing services via Mission CDMO. Distribution is supplemented by global distribution partners covering 40 international markets. Pricing is not publicly disclosed and the company has no outside institutional investors, funding rounds, or public market participation in its disclosure record.

Name

Mission Pharmacal

Legal name

Mission Pharmacal Company

Website

https://missionpharmacal.com

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mission Pharmacal is a privately held, family-owned U.S. pharmaceutical manufacturer, founded in 1946 and headquartered in San Antonio, Texas, producing branded prescription and OTC products across Women's Health, Urology, Dermatology, and Consumer categories, with a wholly-owned generic pharmaceutical subsidiary (BioComp Pharma) and a contract development and manufacturing services business (Mission CDMO).

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Branded pharmaceutical manufacturing
• Women's health therapeutics
• Kidney stone treatment
• Dermatology prescription products
• Contract pharmaceutical manufacturing

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Branded Pharmaceuticals and OTC Products: Mission Pharmacal generates revenue through the manufacture and sale of branded prescription and over-the-counter pharmaceutical products in the therapeutic areas of women's health, urology, and dermatology.
2. Generic Pharmaceuticals: BioComp Pharma, a wholly-owned subsidiary, commercializes generic drugs through turnkey services including labeling, warehousing, distribution, national account sales management, and marketing.
3. Contract Development and Manufacturing: Mission CDMO offers contract development and manufacturing services to pharmaceutical companies requiring manufacturing capabilities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Core offering

Mission Pharmacal is a privately held pharmaceutical manufacturer that develops, produces, and sells branded prescription and over-the-counter products in the therapeutic areas of women's health (prenatal supplements and iron deficiency), urology (kidney stone disease management), and dermatology (skin conditions such as rosacea, acne, and inflammatory disorders). The company also operates BioComp Pharma, a wholly-owned subsidiary providing turnkey commercialization services for generic pharmaceuticals, and Mission CDMO, a contract development and manufacturing organization serving other pharmaceutical companies.

Product overview

Mission Pharmacal is a privately held pharmaceutical company headquartered in San Antonio, Texas, with over 75 years of experience manufacturing and delivering pharmaceutical products. The company operates as a diversified pharmaceutical organization with three core business segments: Branded Pharmaceuticals and OTC Products, Generic Pharmaceuticals (through subsidiary BioComp Pharma), and Contract Development and Manufacturing. Mission's product portfolio spans three primary therapeutic areas—Women's Health, Urology, and Dermatology—alongside Other consumer products. The Women's Health portfolio includes prenatal supplements such as CitraNatal Assure® and CitraNatal® 90 DHA, Ferralet® 90 iron supplement, and Uribel® Tabs. The Urology portfolio features Lithostat® (Acetohydroxamic Acid) and Urocit®-K (Potassium Citrate), which established Mission as a leader in kidney stone disease management. The Dermatology portfolio includes AVAR® Cleanser, AVAR® LS Cleanser, AVAR-e® Emollient Cream, GLYDERM®, OVACE® Plus Cream, OVACE® Plus Lotion, OVACE® Plus Shampoo, OVACE® Plus Wash Cleansing Gel, and Texacort® topical solution. Other products include Dr. Smith's® Diaper Rash Ointment, Oncovite™ Antioxidant Multivitamin, Potassium Iodide Oral Solution, and Thera-Gesic® Dual-Action Pain Relieving Creme. The company operates a manufacturing and development facility in Boerne, Texas, with capabilities to produce powders, tablets, solutions, creams, lotions, gels, and suspensions.

Differentiator

Problem solved

Functional benefit

Brands

• BioComp Pharma: A wholly-owned subsidiary of Mission Pharmacal Company focused on generic pharmaceuticals, offering development, sourcing, commercialization services, and turnkey generics commercialization services including labeling, warehousing, distribution, and national account sales management.

Products and services

• CitraNatal Assure A prenatal supplement product in the Women's Health category, designed to support nutritional needs during pregnancy.
• CitraNatal 90 DHA A prenatal vitamin supplement with DHA (docosahexaenoic acid) for women's health, supporting maternal and fetal nutrition.
• Ferralet 90 An iron supplement product in the Women's Health category, formulated to address iron deficiency.
• Uribel Tabs A prescription medication for urinary tract health management marketed in the Women's Health and Urology therapeutic areas.
• Lithostat (Acetohydroxamic Acid) A medication developed by Mission for the treatment of kidney stone disease, used in the medical management of urological conditions.
• Urocit-K (Potassium Citrate) A potassium citrate medication for kidney stone prevention and treatment, part of Mission's urology portfolio.
• AVAR Cleanser A topical cleanser for dermatological use, part of Mission's dermatology product line.
• AVAR LS Cleanser A low-strength version of the AVAR cleanser for dermatological applications.
• AVAR-e Emollient Cream An emollient cream in the dermatology category, providing moisturizing treatment for skin conditions.
• GLYDERM A dermatological product for skin care treatment.
• OVACE Plus Cream A cream formulation in the OVACE Plus dermatology product line.
• OVACE Plus Lotion A lotion formulation in the OVACE Plus dermatology product line.
• OVACE Plus Shampoo A shampoo product in the OVACE Plus dermatology line for scalp and skin care.
• OVACE Plus Wash Cleansing Gel A cleansing gel in the OVACE Plus dermatology product line.
• Texacort (hydrocortisone) topical solution 2.5% A hydrocortisone topical solution for dermatological conditions.
• Dr. Smith's Diaper Rash Ointment A diaper rash ointment for infant skin care, part of Mission's Other category products.
• Oncovite Antioxidant Multivitamin An antioxidant multivitamin dietary supplement.
• Potassium Iodide Oral Solution (Liquid KI) A potassium iodide oral solution, part of Mission's Other category.
• Thera-Gesic Dual-Action Pain Relieving Creme A topical pain relieving cream for muscle and joint discomfort.
• Mission CDMO Contract Development and Manufacturing Services Contract development and manufacturing organization (CDMO) services provided to pharmaceutical companies utilizing Mission Pharmacal's cGMP-compliant manufacturing capabilities for powders, tablets, solutions, creams, lotions, gels, and suspensions in support of branded and generic product programs.
• BioComp Pharma Generic Pharmaceutical Commercialization Services Turnkey and à la carte generic drug commercialization services provided by BioComp Pharma, including labeling coordination, secure warehousing, U.S. distribution with EDI capabilities, national account sales management, and marketing support for companies lacking their own commercial and distribution infrastructure.

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BioComp Pharma, Inc.coreOEM/ Whitelabel/ Licensing PartnerBioComp Pharma is a wholly-owned subsidiary of Mission Pharmacal Company headquartered in San Antonio, Texas. It provides turnkey and à la carte generic commercialization services including labeling coordination, secure warehousing, U.S. distribution, EDI capabilities, national account sales management, and marketing for companies lacking commercial and distribution infrastructure.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Patheon (Thermo Fisher Scientific): Global CDMO within Thermo Fisher's pharma services segment, offering end-to-end contract development and manufacturing services; a scaled incumbent against which Mission CDMO must compete for outsourced pharma manufacturing contracts.
• Perrigo Company: Large U.S.-headquartered consumer-focused self-care and specialty pharma company with a broad OTC and prescription portfolio; comparable in OTC dermatology and women's health adjacencies though at materially greater scale.
• Catalent: Leading global CDMO with broad dosage-form capabilities including tablets, creams, and solutions; directly comparable to Mission CDMO's contract manufacturing business though at far greater scale and geographic reach.
• Bausch Health (including Ortho Dermatologics): Diversified specialty pharma company with a significant dermatology franchise (Ortho Dermatologics) and broader branded pharma presence; relevant peer given direct overlap with Mission's AVAR and OVACE dermatology lines.
• Endo Pharmaceuticals: Specialty pharmaceutical company focused on branded and generic products in urology, dermatology, and women's health — closely overlapping Mission's core therapeutic categories, though operating at significantly larger scale.

Direct peers

• ANI Pharmaceuticals: Specialty generics and branded pharmaceutical company with a similar therapeutic mix and small-to-mid-cap profile; comparable in focus on niche specialty categories and contract manufacturing services.
• Amneal Pharmaceuticals: U.S. generics and specialty branded pharmaceutical manufacturer with CDMO capabilities (via its affiliate AvKARE and Patterson companies); directly comparable in business model spanning generic, branded specialty, and contract services.
• Camber Pharmaceuticals: Privately held U.S. generics manufacturer with vertically integrated distribution; comparable to Mission's BioComp Pharma business in providing affordable generic alternatives through U.S. distribution infrastructure.
• Upsher-Smith Laboratories: Privately held U.S. specialty and generic pharmaceutical manufacturer of branded and generic products; closely comparable to Mission in therapeutic breadth, scale (mid-size private), and channel strategy (physician/pharmacy-led).

Emerging players

• Almatica Pharma: Privately held specialty pharmaceutical company focused on select therapeutic categories including urology and women's health; smaller and narrower in scope than Mission but competes in adjacent specialty niches.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mission-pharmacal

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mission Pharmacal